841 |
Theoretical Construct: Why BRS May Change the Landscape of Coronary Intervention? |
Patrick W. Serruys |
Apr. 20. 15 |
840 |
Bioresorbable Scaffolds in Complex Coronary Lesions |
Corrado Tamburino |
Apr. 20. 15 |
839 |
Vulnerable Plaque Detection and Treatment: PROSPECT II and PROSPECT ABSORB |
Gregg W. Stone |
Apr. 20. 15 |
838 |
How to Treat? - Functionally Insignificant Vulnerable Plaque: STABLE and PREVENT |
Seung-Jung Park |
Apr. 20. 15 |
837 |
Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study |
Jung-Min Ahn |
Apr. 20. 15 |
836 |
Statin Treatment Can Stabilize Coronary Plaque Vulnerability: A Double-Blind, Randomized Study |
Soo-Jin Kang |
Apr. 20. 15 |
835 |
Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease |
Seung-Jung Park |
Apr. 20. 15 |
834 |
Primary PCI in 2014 |
Cindy L. Grines |
May. 09. 14 |
833 |
CABG Is Best Revascularization in Diabetes |
David Paul Taggart |
May. 09. 14 |
832 |
What Is the Future for Coronary Stenting? |
Spencer B. King III |
May. 09. 14 |